Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration

Alan J. Thompson, D. H. Miller, B Youl, David MacManus, S G Moore, D. P. E. Kingsley, B. E. Kendall, Anthony Feinstein, W. I. McDonald

Neurology · 1992 · 220 citations · 0 references

Concepts

Abstract

In the planning of MRI protocols to monitor disease activity in multiple sclerosis (MS), the clinical subtype needs to be considered. In this serial gadolinium-enhanced MRI study, we demonstrated differences between patients with early relapsing/remitting MS and benign MS in both the production of new lesions and the occurrence of enhancement.